Procedure
ultrasound-guided thermal ablation
ultrasound-guided thermal ablation is a medical procedure with 6 clinical trials. Currently 6 active trials ongoing.
Total Trials
6
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
6(100%)
Phase Distribution
Ph not_applicable
1
17%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
6
trials recruiting
Total Trials
6
all time
Status Distribution
Active(6)
Detailed Status
Recruiting6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
6
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
recruiting6100%
Recent Activity
6 active trials
Showing 5 of 6
recruiting
The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma
NCT06316895
recruitingnot_applicable
The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
NCT06340945
recruiting
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer
NCT06733766
recruiting
Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma
NCT06733740
recruiting
Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules
NCT06733753
Clinical Trials (6)
Showing 6 of 6 trials
NCT06316895
The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma
NCT06340945Not Applicable
The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
NCT06733766
Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer
NCT06733740
Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma
NCT06733753
Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules
NCT06729762
Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
All 6 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 6